Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Catheter Precision, Inc. Common Stock (NY:VTAK)

2.300 +0.080 (+3.60%)
Official Closing Price Updated: 4:10 PM EST, Jan 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Catheter Precision, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Catheter Precision And 2 Other Stocks Under $2 Insiders Are Buying ↗
The Dow Jones index closed higher by over 100 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
Medical Spotlight: Catheter Precision, Inc. (NYSE American: VTAK) Showcased in EP Lab Digest, Fuelling Positive Market Momentum
Via AB Newswire
News headline image
Catheter Precision, Inc. (VTAK) Secures New Distributor in Brazil for LockeT
Via ACCESSWIRE
News headline image
Catheter Precision, Inc. (NYSE American:VTAK) Presenting at the Sequire Investor Summit in Puerto Rico
Via ACCESSWIRE
News headline image
Tilray Brands And 2 Other Penny Stocks Insiders Are Buying ↗
The Dow Jones index closed higher by over 200 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Topics Stocks
News headline image
CORRECTION: Catheter Precision, Inc.'s (VTAK) Board Authorizes its CEO and Chairman to Make "Open Market" Purchases of Company Shares
Via ACCESSWIRE
News headline image
Catheter Precision, Inc. (VTAK) Receives Additional Patents for LockeT in Great Britain and the European Market
Via ACCESSWIRE
News headline image
Catheter Precision’s VIVO is Now Eligible for National Reimbursement in the UK
Via ACCESSWIRE
News headline image
Catheter Precision’s VIVO System Featured in Electrophysiology Publication
Via ACCESSWIRE
Catheter Precision Inc (NYSE American: VTAK) announces Q4 and FY23 Results and Authorizes CEO to Make “Open Market” Purchases of Company Shares
Via AB Newswire
News headline image
Cather Precision, Inc.'s (VTAK) Board Authorizes its CEO and Chairman to Make "Open Market" Purchases of Company Shares
Via ACCESSWIRE
“Catheter Precision Inc. (NYSE American: VTAK) Recognized as Pioneering Innovator in Medical Manufacturing by ‘MedTech Outlook”
Via AB Newswire
News headline image
CATHETER PRECISION, INC. (VTAK) Reports Unaudited Preliminary Fourth Quarter and Full Year 2023 Results
Via ACCESSWIRE
“Catheter Precision, Inc. (NYSE American: VTAK) Achieves 50 Patents Milestone for LockeT, Unveils Leadership Transition”
Via AB Newswire
Topics Intellectual Property
News headline image
Catheter Precision, Inc. (VTAK) Announces Changes to Executive Management and Board of Directors
Via ACCESSWIRE
“Holiday Season Stock Surge: Exploring Potential Opportunities for 2024” INBS, VTAK, KAVL, CLNV, BULT
Via AB Newswire
News headline image
Catheter Precision, Inc. Reports Third Quarter Results of Operations and Filing of Third Quarter 10-Q
Via ACCESSWIRE
Catheter Precision, Inc. (NYSE American: VTAK) Releases Q2 2023 Financials and Corporate Highlights
Via AB Newswire
Topics Intellectual Property
News headline image
VTAK Stock Earnings: Catheter Precision, Inc. Common Stock Reported Results for Q2 2023 ↗
Catheter Precision, Inc. Common Stock just reported results for the second quarter of 2023. 
Via InvestorPlace
News headline image
CATHETER PRECISION, INC. Reports Filing of 10-Q and Second Quarter Results of Operations
Via ACCESSWIRE
“Unlocking Potential: Emerging Growth’s Rising Stars Look Now! ASPI, VTAK, INBS, HNRC
Via AB Newswire
News headline image
Catheter Precision, Inc. (NYSE American:VTAK) Presenting at the Emerging Growth Conference on December 6, 2023
Via ACCESSWIRE
Catheter Precision Inc. (NYSE American: VTAK) Spotlighted in “Cardiac Rhythm News” for Revolutionary Advances in Cardiac Treatment”
Via AB Newswire
News headline image
Catheter Precision's (VTAK) First Successful VIVO(TM) Cases Completed in Croatia Sets Stage for Expansion into South-Eastern Europe
Via ACCESSWIRE
Revolutionizing Breakthroughs in Cardiac Diagnosis and Treatment: Boston Scientific Corporation (NYSE: BSX) vs Catheter Precision (NYSEAMERICAN: VTAK)
Via AB Newswire
“Unleashing a Medical Revolution: Transformative Breakthroughs in Diagnosis and Treatment” VTAK, ALDX, MNPR, INBS, SIEN
Via AB Newswire
Catheter Precision (NYSEAMERICAN: VTAK) “Revolutionizing Cardiac Arrhythmia Diagnosis: VIVO™ 3D Mapping System vs. Traditional Methods”
Via AB Newswire
Catheter Precision Inc. (NYSEAMERICAN: VTAK) Revolutionizing Heart Health, VTAK, LMDX, AKU, INPX, AZN
Via AB Newswire
“Discoveries Unlocked: Nasdaq Small-Cap Biotech Medical Stocks Emerge” VTAK, MNTS, MREO, PCSA, MTNB
Via AB Newswire
Catheter Precision Inc. (NYSE American: VTAK) Nasdaq/NYSE Stocks Ignite Multiple Buzzers (AVTX, SPCB, INTZ)
Via AB Newswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.